Posted on 9/5/19
4 Things You Need To Know About The Potential $200 Billion Altria-Philip Morris Merger
SummaryAltria and Philip Morris have been battered recently by news that they are considering merging, creating a lot of uncertainty and dividend safety angst.A $200 billion . . .
Posted on 8/2/19
Pfizer Might Cut Its Dividend: 3 Things Investors Need To Know
Pfizer is a defensive high-yield blue chip owned by millions of conservative income investors for safe and steadily rising dividends in all economic conditions. The Upjohn-Mylan . . .
Posted on 8/2/19
Pfizer Might Cut Its Dividend: 3 Things Investors Need To Know
Pfizer is a defensive high-yield blue chip owned by millions of conservative income investors for safe and steadily rising dividends in all economic conditions.The Upjohn-Mylan merger . . .
Posted on 7/31/19
AT&T And Verizon: One Is Clearly The Better High-Yield Buy Today
SummaryAT&T and Verizon are beloved by conservative income investors and for good reason.They are recession-resistant telecom utilities that are able to generate inflation-adjusted generous income, in . . .
Posted on 4/9/19
3 Reasons Bristol-Myers Could Become One Of The Best Investments Of The Next 5 Years
Summary Now that my retirement portfolio is recession ready, with zero margin and a total focus on blue-chip dividend stocks, I'm able to aggressively buy deep . . .
Posted on 4/9/19
3 Reasons Bristol-Myers Could Become One Of The Best Investments Of The Next 5 Years
SummaryNow that my retirement portfolio is recession ready, with zero margin and a total focus on blue-chip dividend stocks, I'm able to aggressively buy deep value . . .
Posted on 1/31/19
Philip Morris Vs. British American: One Clear Winner
SummaryTobacco companies have historically made excellent high-yield investments delivering steady dividend growth and market-crushing returns.Today fear of rising anti-tobacco regulations and ongoing declines in smoking rates . . .
Posted on 1/16/19
3 Reasons Bristol-Myers' $90 Billion Mega-Merger Makes It A Must Own Stock
Summary The worst correction in a decade has left lots of blue-chips trading at attractive prices. Bristol-Myers Squibb has been pummelled especially hard due to negative . . .
Posted on 1/16/19
3 Reasons Bristol-Myers' $90 Billion Mega-Merger Makes It A Must Own Stock
Summary The worst correction in a decade has left lots of blue-chips trading at attractive prices. Bristol-Myers Squibb has been pummelled especially hard due to negative . . .
Posted on 1/16/19
3 Reasons Bristol-Myers' $90 Billion Mega-Merger Makes It A Must Own Stock
SummaryThe worst correction in a decade has left lots of blue-chips trading at attractive prices.Bristol-Myers Squibb has been pummelled especially hard due to negative pharma sentiment . . .
Posted on 10/30/17
CVS And Aetna: A Marriage Made In Money Hell
It's no secret that fears over Amazon (NASDAQ:AMZN) breaking into the mail order drug delivery business, and also potentially launching its own pharmacy benefits manager or . . .
Posted on 10/4/17
3 Reasons To Avoid This Legendary Dividend King In Favor Of A Far Superior Alternative
When it comes to low-risk dividend growth investing, it's hard to go wrong with legendary dividend kings such as Johnson & Johnson (JNJ), which has rewarded . . .
Posted on 9/12/17
AT&T, Verizon, And The Insanity Of Wall Street
Big telecom companies like AT&T (NYSE:T) and Verizon (NYSE:VZ) are viewed as high yield utilities and strong bond alternatives, and for good reason.After all, these are . . .
Posted on 6/6/17
Johnson & Johnson: One Of The Best Long-Term Dividend Investments In The World But Not At This Price
When it comes to high-yield dividend growth legends, there are few lower risk names than Johnson & Johnson.JNJ's massive scale and diversification means that its 55-year . . .
Houston
